Problems of drug evaluation in cutaneous leishmaniasis.
D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use; D000818:Animals; D000965:Antimony / Q000008:administration & dosage / Q000627:therapeutic use; D006224:Cricetinae; D005069:Evaluation Studies as Topic; D005942:Gluconates / Q000008:administration & dosage / Q000627:therapeutic use; D006168:Guinea Pigs; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D007897:Leishmaniasis, Mucocutaneous / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D051379:Mice; D013012:Sorbitol / Q000008:administration & dosage / Q000627:therapeutic use; D014020:Tissue Extracts; D014774:Virulence
D005942:Gluconates; D014020:Tissue Extracts; D013012:Sorbitol; D000666:Amphotericin B; D000965:Antimony